LFA
LLY icon

Livelsberger Financial Advisory’s Eli Lilly LLY Stock Holding History

Livelsberger Financial Advisory’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-232
Closed -$135K – 119
2023
Q4 		$135K Buy
+232
New +$135K 0.12% 101

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Livelsberger Financial Advisory's LLY Position: Q1 2024 in Review

Livelsberger Financial Advisory sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 232 shares — an estimated $135K sold.

Livelsberger Financial Advisory first reported a position in LLY in Q4 2023 and held it in 1 quarter. The position peaked at $135K in Q4 2023. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Livelsberger Financial Advisory reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Livelsberger Financial Advisory sold 232 Eli Lilly shares in Q1 2024, an estimated $135K.
  • Livelsberger Financial Advisory first reported a position in Eli Lilly in Q4 2023 and held it in 1 quarter.
  • Livelsberger Financial Advisory's Eli Lilly position peaked at $135K in Q4 2023.
  • 3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Livelsberger Financial Advisory's 13F filing for Q1 2024, filed 22 May 2024.